2020
DOI: 10.1186/s13287-020-01767-8
|View full text |Cite
|
Sign up to set email alerts
|

Extracellular vesicles produced by bone marrow mesenchymal stem cells attenuate renal fibrosis, in part by inhibiting the RhoA/ROCK pathway, in a UUO rat model

Abstract: Background: Extracellular vesicles produced by bone marrow mesenchymal stem cells (BMSC-EVs) can play important roles in the repair of injured tissues. Though numerous studies have reported the effect of EVs on renal fibrosis, the underlying mechanisms remain unclear. We hypothesized that BMSC-EVs containing milk fat globuleepidermal growth factor-factor 8 (MFG-E8) could attenuate renal fibrosis by inhibiting the RhoA/ROCK pathway. Methods: We investigated whether BMSC-EVs have anti-fibrotic effects in a rat m… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
44
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 54 publications
(49 citation statements)
references
References 45 publications
5
44
0
Order By: Relevance
“…Oxidative stress is a phenomenon resulted from accumulation of ROS, which impairs the function and structures of cells and tissues ( 136 , 149 ). BMSC-EVs could protect cells from toxic effects of peroxide via reducing malondialdehyde (MDA) and increasing superoxide dismutase 1 (SOD1) and catalase expression ( 151 ). Moreover, MSC-EVs were likely to have a mitochondrial (MIT)-protective effect.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Oxidative stress is a phenomenon resulted from accumulation of ROS, which impairs the function and structures of cells and tissues ( 136 , 149 ). BMSC-EVs could protect cells from toxic effects of peroxide via reducing malondialdehyde (MDA) and increasing superoxide dismutase 1 (SOD1) and catalase expression ( 151 ). Moreover, MSC-EVs were likely to have a mitochondrial (MIT)-protective effect.…”
Section: Methodsmentioning
confidence: 99%
“…Moreover, MSC-EVs were likely to have a mitochondrial (MIT)-protective effect. The compromised mitochondrial membrane potential (MMP) or ATP level was rescued, and ROS level was reduced significantly after MSC-EVs treatment ( 151 , 152 ). For this reason, studies about the mechanism of MSC-EVs in ameliorating POI, should not only focus on the effect of anti-apoptosis of GCs under lower levels of ROS, but also further explore the influence of MSC-EVs on MIT dysfunction of GCs or oocytes.…”
Section: Methodsmentioning
confidence: 99%
“…The anti-inflammatory effects of EVs can be attributed to their paracrine delivery of immunomodulatory molecules or expression of surface proteins that minimises infiltration of immune cells, such as macrophages, T cells, and NK cells [ 134 ]. BM-MSC-exosomes downregulated pro-inflammatory cytokines (IL-6, IL-1β, IFN-γ, TNF-α) and stimulated anti-inflammatory cytokines (IL-10) in rodents with IRI [ 113 ], unilateral ureteral obstruction (UUO) [ 135 ], or gentamicin- [ 98 ] or cisplatin-induced AKI [ 107 , 108 , 136 ]. Additionally, umbilical-MSC-exosomes upregulated miR-146b, leading to reduced IRAK1 expression and NF-κB transcriptional activity in TECs in mice with sepsis-associated AKI [ 137 ].…”
Section: Nephroprotective Role Of Msc-evs In Akimentioning
confidence: 99%
“…Milk fat globule-epidermal growth factor-factor 8 (MFG-E8) is a glycoprotein that inhibits the RhoA/ROCK signalling pathway. BM-MSC-EVs delivered MFG-E8 to rats with UUO and reduced inflammation, macrophage infiltration, mitochondrial damage, apoptosis, oxidative stress, and the EMT within two weeks [ 135 ].…”
Section: Biological Cargo Carried By Msc-evs To Alleviate Aki and Ckdmentioning
confidence: 99%
“…Milk globule epidermal growth factor 8 (MFG-E8) is a secretory multifunctional glycoprotein that usually exists in human milk globules. Shi et al [ 113 ] showed that BM-MSC-EVs could decrease renal fibrosis by producing MFG-E8, which suppressed the RhoA/ROCK pathway. Ninichuk et al [ 114 ] injected BM-MSCs via the tail vein in COL4A3-deficient mice (Alport disease model) and showed that BM-MSCs could decrease BUN and Scr and inhibit glomerulosclerosis and renal fibrosis, but EVGF and BMP7 were not changed.…”
Section: Preclinical Studies Of Stem Cell Therapy For Renal Fibrosismentioning
confidence: 99%